Frontiers in Cardiovascular Medicine | |
Extracellular Vesicles as Biomarkers in Cardiovascular Disease; Chances and Risks | |
Annemiek Dickhout1  | |
关键词: microparticle; atherosclerosis; vascular remodeling; diagnostic; platelet; endothelial cell; monocyte; | |
DOI : 10.3389/fcvm.2018.00113 | |
学科分类:心脏病和心血管学 | |
来源: Frontiers | |
【 摘 要 】
The field of extracellular vesicles (EV) is rapidly expanding, also within cardiovascular diseases. Besides their exciting roles in cell-to-cell communication, EV have the potential to serve as excellent biomarkers, since their counts, content, and origin might provide useful information about the pathophysiology of cardiovascular disorders. Various studies have already indicated associations of EV counts and content with cardiovascular diseases. However, EV research is complicated by several factors, most notably the small size of EV. In this review, the advantages and drawbacks of EV-related methods and applications as biomarkers are highlighted.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201904025861477ZK.pdf | 422KB | download |